June 17, 2020 / 6:38 AM / 18 days ago

BRIEF-Reneuron Group Gets FDA, MHRA Nod For Expanded Phase 2A Study In RP Patients

June 17 (Reuters) - ReNeuron Group PLC:

* RENEURON GROUP PLC - REGULATORY APPROVALS AND PROGRAMME UPDATE

* RENEURON GROUP - GOT REGULATORY APPROVAL FROM BOTH FDA AND MHRA FOR EXPANDED PHASE 2A STUDY IN RP PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below